Gastrointestinal effects represent the most common concern: Nausea and vomiting : May be pronounced when initiating either medication or during Wegovy dose escalation Diarrhoea or constipation : Both medications can affect bowel habits Reduced appetite : Wegovy's appetite-suppressing effects combined with SSRI-related nausea may significantly reduce food intake Abdominal discomfort : Bloating, dyspepsia, or gastric pain may occur To minimise gastrointestinal distress, consider taking escitalopram with food and following the gradual Wegovy dose escalation schedule precisely
The main foods in this diet include blueberries, beets, nuts, lean meats and broccoli
Pharmacol Rep
(2017) Structure-guided screening for functionally selective D2 dopamine receptor ligands from a virtual chemical library, ACS Chem
Instead of focusing on how treatment affects markers of glycemic control, which has not shown benefit, treatments should be based on anticipated reductions in cardiovascular and kidney disease outcomes
General handling recommendations include: Laboratories should always implement handling procedures that align with their internal quality systems and research protocols